ImmunoCellular announced that ICT-107, its dendritic cell-based vaccine, demonstrated a statistically significant increase in progression-free survival, or PFS, in patients with newly diagnosed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈